Profound Medical (PROF) vs Treace Medical Concepts, Inc. (TMCI)
- Profound Medical PROF 6.01 −4.75%
- Treace Medical Concepts, Inc. TMCI 3.87 −6.07%
Profound Medical and Treace Medical Concepts, Inc. are both Medical Devices companies. Treace Medical Concepts, Inc. is the larger, with a market value of $267.9M against $230.5M — 1.2× the size. Profound Medical grew revenue faster over the last twelve months: 61.2% against −3.95%. Treace Medical Concepts, Inc. has the higher net margin (−29.0% vs −171.6%) and the higher return on invested capital (−43.0% vs −137.8%). Across the 18 metrics below, Treace Medical Concepts, Inc. leads on 14 and Profound Medical on 4.
Valuation
Profitability
| Metric | PROF | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.79% | 79.45% | 56.01% |
| Operating margin | (185.31%) | (26.17%) | (15.03%) |
| Net margin | (171.56%) | (28.99%) | (20.40%) |
| Free cash flow margin | (189.15%) | (12.20%) | (7.24%) |
| Return on equity | (73.53%) | (71.99%) | (15.32%) |
| Return on assets | (58.44%) | (30.72%) | (19.72%) |
| Return on invested capital | (137.78%) | (42.96%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack